$NA
Nano Labs Ltd
CIK:0001872302|SEC Filings
Consolidated Statements of Operations and Comprehensive Income (Loss) |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Dec. 31, 2025
CNY (¥)
¥ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
CNY (¥)
¥ / shares
shares
|
Dec. 31, 2023
CNY (¥)
¥ / shares
shares
|
|||
| Income Statement [Abstract] | ||||||
| Net revenues | ¥ 27,006,744 | $ 3,842,298 | ¥ 40,595,916 | ¥ 78,335,376 | ||
| Cost of revenues | (66,797,041) | (9,503,335) | (28,993,601) | (181,784,576) | ||
| Gross profit (loss) | (39,790,297) | (5,661,037) | 11,602,315 | (103,449,200) | ||
| Operating income (expenses): | ||||||
| Selling and marketing expenses | (4,719,282) | (671,421) | (9,136,203) | (15,332,523) | ||
| General and administrative expenses | (54,605,025) | (7,768,755) | (50,832,703) | (53,402,101) | ||
| Research and development expenses | (8,057,816) | (1,146,400) | (50,145,125) | (88,601,470) | ||
| Change in fair value of cryptocurrencies | 178,565,656 | 25,404,857 | (15,744,170) | |||
| Total operating income (expenses) | 111,183,533 | 15,818,281 | (125,858,201) | (157,336,094) | ||
| Profit (loss) from operations | 71,393,236 | 10,157,244 | (114,255,886) | (260,785,294) | ||
| Other income (expenses): | ||||||
| Finance expenses | (618,062) | (87,933) | (1,386,506) | (920,055) | ||
| Interest expense | (16,938,237) | (2,409,833) | (6,913,314) | |||
| Interest income | 46,804 | 6,659 | 504,348 | 489,098 | ||
| Change in fair value of borrowings denominated in cryptocurrencies | 41,978,170 | 5,972,310 | ||||
| Other income | 39,945,315 | 5,683,092 | 3,216,168 | 7,111,093 | ||
| Other expenses | (9,859,628) | (1,402,747) | (703,859) | (264,290) | ||
| Total other income (expenses) | 54,554,362 | 7,761,548 | (5,283,163) | 6,415,846 | ||
| Income (loss) before income tax provision | 125,947,598 | 17,918,792 | (119,539,049) | (254,369,448) | ||
| Income tax provision | 17,394 | |||||
| Net income (loss) | 125,947,598 | 17,918,792 | (119,539,049) | (254,352,054) | ||
| Less: net loss attributable to noncontrolling interests | (9,518,442) | (1,354,206) | (6,352,001) | (1,528,282) | ||
| Net income (loss) attributable to Nano Labs Ltd | 135,466,040 | 19,272,998 | (113,187,048) | (252,823,772) | ||
| Comprehensive income (loss): | ||||||
| Net income (loss) | 125,947,598 | 17,918,792 | (119,539,049) | (254,352,054) | ||
| Other comprehensive income (loss): | ||||||
| Foreign currency translation adjustment | (16,093,836) | (2,289,699) | 6,392,294 | 155,159 | ||
| Total comprehensive income (loss) | 109,853,762 | 15,629,093 | (113,146,755) | (254,196,895) | ||
| Less: comprehensive loss attributable to noncontrolling interests | (9,514,430) | (1,353,635) | (6,352,502) | (1,528,352) | ||
| Comprehensive income (loss) attributable to Nano Labs Ltd | ¥ 119,368,192 | $ 16,982,728 | ¥ (106,794,253) | ¥ (252,668,543) | ||
| Net income (loss) per ordinary share attributable to Nano Labs Ltd | ||||||
| –Basic (in Dollars per share and Yuan Renminbi per share) | (per share) | [1] | ¥ 6.82 | $ 0.97 | ¥ (14.06) | ¥ (42.94) | |
| –Diluted (in Dollars per share and Yuan Renminbi per share) | (per share) | [1] | ¥ 6.82 | $ 0.97 | ¥ (14.06) | ¥ (42.94) | |
| Weighted average number of shares used in per share calculation: | ||||||
| – Basic (in Shares) | [1] | 19,858,117 | 19,858,117 | 8,049,592 | 5,888,507 | |
| – Diluted (in Shares) | [1] | 19,862,161 | 19,862,161 | 8,049,592 | 5,888,507 | |
| ||||||
Consolidated Balance Sheets |
Dec. 31, 2025
CNY (¥)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
CNY (¥)
|
|---|---|---|---|
| Current assets: | |||
| Cash and cash equivalents | ¥ 8,502,357 | $ 1,209,646 | ¥ 32,431,081 |
| Restricted cash | 1,347,795 | 191,753 | 418,722 |
| Accounts receivable, net | 281,446 | 40,042 | 572,803 |
| Short-term investments | 26,214,992 | 3,729,654 | |
| Inventories, net | 13,693,374 | 1,948,181 | 29,866,418 |
| Prepayments | 7,567,871 | 1,076,695 | 4,606,066 |
| Receivable for cryptocurrencies collateral | 20,387,316 | 2,900,540 | |
| Cryptocurrencies, current | 343,812,102 | 48,914,765 | 242,889,085 |
| Other current assets | 9,057,772 | 1,288,665 | 26,908,797 |
| Total current assets | 430,865,025 | 61,299,941 | 337,692,972 |
| Non-current assets: | |||
| Long-term investment | 2,000,000 | 284,544 | |
| Property, plant and equipment, net | 182,630,671 | 25,983,194 | 197,341,915 |
| Intangible asset, net | 45,759,600 | 6,510,300 | 46,745,444 |
| Value-added tax recoverables, non-current | 30,414,877 | 4,327,179 | 28,949,636 |
| Cryptocurrencies, non-current | 424,743,318 | 60,428,995 | |
| Operating lease right-of-use assets | 3,090,851 | 439,741 | 5,203,525 |
| Total non-current assets | 688,639,317 | 97,973,953 | 278,240,520 |
| TOTAL ASSETS | 1,119,504,342 | 159,273,894 | 615,933,492 |
| Current liabilities: | |||
| Short-term debts | 43,000,000 | 6,117,687 | 18,000,000 |
| Current portion of long-term debts | 6,890,000 | 980,253 | 5,350,000 |
| Accounts payable | 19,424,629 | 2,763,577 | 18,101,451 |
| Advance from customers | 69,314,154 | 9,861,449 | 98,895,905 |
| Borrowings denominated in cryptocurrencies | 11,948,960 | 1,700,000 | |
| Operating lease liabilities, current | 1,125,674 | 160,152 | 1,914,109 |
| Other current liabilities | 54,303,126 | 7,725,803 | 67,163,217 |
| Total current liabilities | 206,006,543 | 29,308,921 | 209,424,682 |
| Non-current liabilities: | |||
| Long-term debts | 170,902,834 | 24,314,653 | 170,683,636 |
| Operating lease liabilities, non-current | 1,696,750 | 241,400 | 2,917,350 |
| Total liabilities | 378,606,127 | 53,864,974 | 383,025,668 |
| Shareholders’ equity: | |||
| Treasury shares | (1,666,859) | (237,147) | |
| Additional paid-in capital | 1,180,196,429 | 167,908,666 | 780,499,664 |
| Accumulated deficit | (429,752,701) | (61,141,689) | (565,218,741) |
| Statutory reserves | 6,647,109 | 945,696 | 6,647,109 |
| Accumulated other comprehensive income (loss) | (7,450,495) | (1,059,995) | 8,647,353 |
| Total Nano Labs Ltd shareholders’ equity | 748,293,942 | 106,461,123 | 230,789,121 |
| Noncontrolling interests | (7,395,727) | (1,052,203) | 2,118,703 |
| Total shareholders’ equity | 740,898,215 | 105,408,920 | 232,907,824 |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | 1,119,504,342 | 159,273,894 | 615,933,492 |
| Class A Ordinary Shares | |||
| Shareholders’ equity: | |||
| Ordinary shares, Value | 283,565 | 40,343 | 176,842 |
| Class B Ordinary Shares | |||
| Shareholders’ equity: | |||
| Ordinary shares, Value | ¥ 36,894 | $ 5,249 | ¥ 36,894 |